309 related articles for article (PubMed ID: 25565812)
1. Formulation and evaluation of a topical niosomal gel containing a combination of benzoyl peroxide and tretinoin for antiacne activity.
Gupta A; Singh S; Kotla NG; Webster TJ
Int J Nanomedicine; 2015; 10():171-82. PubMed ID: 25565812
[TBL] [Abstract][Full Text] [Related]
2. Development and characterization of a novel antiacne niosomal gel of rosmarinic acid.
Budhiraja A; Dhingra G
Drug Deliv; 2015; 22(6):723-30. PubMed ID: 24786487
[TBL] [Abstract][Full Text] [Related]
3. Formulation of Niosomal Gel for Enhanced Transdermal Lornoxicam Delivery: In-Vitro and In-Vivo Evaluation.
El-Ridy MS; Yehia SA; Mohsen AM; El-Awdan SA; Darwish AB
Curr Drug Deliv; 2018; 15(1):122-133. PubMed ID: 28240177
[TBL] [Abstract][Full Text] [Related]
4. Codelivery of benzoyl peroxide & adapalene using modified liposomal gel for improved acne therapy.
Jain S; Kale DP; Swami R; Katiyar SS
Nanomedicine (Lond); 2018 Jun; 13(12):1481-1493. PubMed ID: 29972675
[TBL] [Abstract][Full Text] [Related]
5. Formulation and Characterization of a 3D-Printed Cryptotanshinone-Loaded Niosomal Hydrogel for Topical Therapy of Acne.
Wang Z; Liu L; Xiang S; Jiang C; Wu W; Ruan S; Du Q; Chen T; Xue Y; Chen H; Weng L; Zhu H; Shen Q; Liu Q
AAPS PharmSciTech; 2020 May; 21(5):159. PubMed ID: 32476076
[TBL] [Abstract][Full Text] [Related]
6. Preparation and evaluation of optimized zolmitriptan niosomal emulgel.
Mohamed MI; Abdelbary AA; Kandil SM; Mahmoud TM
Drug Dev Ind Pharm; 2019 Jul; 45(7):1157-1167. PubMed ID: 30919700
[No Abstract] [Full Text] [Related]
7. Niosome-encapsulated Doxycycline Hyclate for Potentiation of Acne Therapy: Formulation and Characterization.
Kashani-Asadi-Jafari F; Hadjizadeh A
Pharm Nanotechnol; 2022; 10(1):56-68. PubMed ID: 35209832
[TBL] [Abstract][Full Text] [Related]
8. Community-based trial results of combination clindamycin 1%--benzoyl peroxide 5% topical gel plus tretinoin microsphere gel 0.04% or 0.1% or adapalene gel 0.1% in the treatment of moderate to severe acne.
Kircik L
Cutis; 2007 Jul; 80(1 Suppl):10-4. PubMed ID: 17824581
[TBL] [Abstract][Full Text] [Related]
9. Formulation of niosomal gel for enhanced transdermal lopinavir delivery and its comparative evaluation with ethosomal gel.
Patel KK; Kumar P; Thakkar HP
AAPS PharmSciTech; 2012 Dec; 13(4):1502-10. PubMed ID: 23104306
[TBL] [Abstract][Full Text] [Related]
10. A double-blind, randomized, bilateral comparison of skin irritancy following application of the combination acne products clindamycin/tretinoin and benzoyl peroxide/adapalene.
Goreshi R; Samrao A; Ehst BD
J Drugs Dermatol; 2012 Dec; 11(12):1422-6. PubMed ID: 23377511
[TBL] [Abstract][Full Text] [Related]
11. Formulation and optimization of lacidipine loaded niosomal gel for transdermal delivery: In-vitro characterization and in-vivo activity.
Qumbar M; Ameeduzzafar ; Imam SS; Ali J; Ahmad J; Ali A
Biomed Pharmacother; 2017 Sep; 93():255-266. PubMed ID: 28738502
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of micronized tretinoin gel (0.05%) in treating adolescent acne.
Torok HM; Pillai R
J Drugs Dermatol; 2011 Jun; 10(6):647-52. PubMed ID: 21637905
[TBL] [Abstract][Full Text] [Related]
13. Randomized tolerability analysis of clindamycin phosphate 1.2%-tretinoin 0.025% gel used with benzoyl peroxide wash 4% for acne vulgaris.
Draelos ZD; Potts A; Alió Saenz AB;
Cutis; 2010 Dec; 86(6):310-8. PubMed ID: 21284283
[TBL] [Abstract][Full Text] [Related]
14. Optimization, physicochemical characterization, and antimicrobial activity of a novel simvastatin nano-niosomal gel against E. coli and S. aureus.
Akbarzadeh I; Keramati M; Azadi A; Afzali E; Shahbazi R; Chiani M; Norouzian D; Bakhshandeh H
Chem Phys Lipids; 2021 Jan; 234():105019. PubMed ID: 33232724
[TBL] [Abstract][Full Text] [Related]
15. Optimization, characterization, and follicular targeting assessment of tretinoin and bicalutamide loaded niosomes.
Ghasemiyeh P; Moradishooli F; Daneshamouz S; Heidari R; Niroumand U; Mohammadi-Samani S
Sci Rep; 2023 Nov; 13(1):20023. PubMed ID: 37973805
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study.
Eichenfield LF; Alió Sáenz AB
J Drugs Dermatol; 2011 Dec; 10(12):1382-96. PubMed ID: 22134562
[TBL] [Abstract][Full Text] [Related]
17. Formulation and Evaluation of Niosomal in situ Nasal Gel of a Serotonin Receptor Agonist, Buspirone Hydrochloride for the Brain Delivery via Intranasal Route.
Mathure D; Madan JR; Gujar KN; Tupsamundre A; Ranpise HA; Dua K
Pharm Nanotechnol; 2018; 6(1):69-78. PubMed ID: 29380709
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind, multicenter, parallel group study to compare relative efficacies of the topical gels 3% erythromycin/5% benzoyl peroxide and 0.025% tretinoin/erythromycin 4% in the treatment of moderate acne vulgaris of the face.
Gupta AK; Lynde CW; Kunynetz RA; Amin S; Choi K; Goldstein E
J Cutan Med Surg; 2003; 7(1):31-7. PubMed ID: 12362264
[TBL] [Abstract][Full Text] [Related]
19. Liposome-based combination therapy for acne treatment.
Eroğlu İ; Aslan M; Yaman Ü; Gultekinoglu M; Çalamak S; Kart D; Ulubayram K
J Liposome Res; 2020 Sep; 30(3):263-273. PubMed ID: 31185768
[TBL] [Abstract][Full Text] [Related]
20. Sorbitan ester niosomes for topical delivery of rofecoxib.
Das MK; Palei NN
Indian J Exp Biol; 2011 Jun; 49(6):438-45. PubMed ID: 21702223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
